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Abstract
Background: Human equilibrative nucleoside transporters (hENTs) 1-3 and human concentrative nucleoside
transporters (hCNTs) 1-3 in the human choroid plexus (hCP) play a role in the homeostasis of adenosine and other
naturally occurring nucleosides in the brain; in addition, hENT1, hENT2 and hCNT3 mediate membrane transport of
nucleoside reverse transcriptase inhibitors that could be used to treat HIV infection, 3’-azido-3’-deoxythymidine, 2’3’-
dideoxycytidine and 2’3’-dideoxyinosine. This study aimed to explore the expression levels and functional activities
of hENTs 1-3 and hCNTs 1-3 in human choroid plexus.
Methods: Freshly-isolated pieces of lateral ventricle hCP, removed for various clinical reasons during neurosurgery,
were obtained under Local Ethics Committee approval. Quantification of mRNAs that encoded hENTs and hCNTs
was performed by the hydrolysis probes-based reverse transcription real time-polymerase chain reaction (RT-qPCR);
for each gene of interest and for 18 S ribosomal RNA, which was an endogenous control, the efficiency of PCR
reaction (E) and the quantification cycle (Cq) were calculated. The uptake of [
3H]inosine by the choroid plexus
pieces was investigated to explore the functional activity of hENTs and hCNTs in the hCP.
Results: RT-qPCR revealed that the mRNA encoding the intracellularly located transporter hENT3 was the most
abundant, with E
-Cq value being only about 40 fold less that the E
-Cq value for 18 S ribosomal RNA; mRNAs
encoding hENT1, hENT2 and hCNT3 were much less abundant than mRNA for the hENT3, while mRNAs encoding
hCNT1 and hCNT2 were of very low abundance and not detectable. Uptake of [
3H]inosine by the CP samples was
linear and consisted of an Na
+-dependent component, which was probably mediated by hCNT3, and Na
+-independent component, mediated by hENTs. The latter component was not sensitive to inhibition by S-(4-
nitrobenzyl)-6-thioinosine (NBMPR), when used at a concentration of 0.5 μM, a finding that excluded the
involvement of hENT1, but it was very substantially inhibited by 10 μM NBMPR, a finding that suggested the
involvement of hENT2 in uptake.
Conclusion: Transcripts for hENT1-3 and hCNT3 were detected in human CP; mRNA for hENT3, an intracellularly
located nucleoside transporter, was the most abundant. Human CP took up radiolabelled inosine by both
concentrative and equilibrative processes. Concentrative uptake was probably mediated by hCNT3; the equilibrative
uptake was mediated only by hENT2. The hENT1 transport activity was absent, which could suggest either that this
protein was absent in the CP cells or that it was confined to the basolateral side of the CP epithelium.
Background
Nucleosides play key roles as precursors for nucleotide
synthesis by salvage pathways in a number of human tis-
sues. Their cellular uptake and release are dependent on
the activity of one or more members of two families of
membrane proteins, the human equilibrative nucleoside
transporters (hENTs) and the human concentrative
nucleoside transporters (hCNTs). Concentrative nucleo-
side transport processes are found primarily in specia-
lized epithelial tissues [1]; the major concentrative
transport processes, cit, cif and cib, which are, respec-
tively, pyrimidine nucleoside-preferring, purine nucleo-
side-preferring and of broad specificity, are mediated in
humans by the proteins hCNT1, hCNT2 and hCNT3
[1]. Equilibrative nucleoside transport processes appear
to be ubiquitous but differ in their sensitivities to inhibi-
tion by the nucleoside analogue S-(4-Nitrobenzyl)-6-
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These processes are mediated by the proteins hENT1,
hENT2 [2] (with hENT1 being 1000-fold more sensitive
to NBMPR inhibition than hENT2 [2]) and hENT3,
which is predominantly located intracellularly, in lyso-
somes [3] and mitochondria [4], although human pla-
cental cells expressed this protein in the cell membrane
[4].
Several homeostatic mechanisms maintain adenosine
concentrations in brain interstitial fluid (ISF) within nar-
row limits and, therefore, influence adenosine neuromo-
dulatory effects in the CNS: cellular uptake into
neurones/glia, with trapping by phosphorylation via ade-
nosine kinase (AK, ATP: adenosine 5’-phosphotransfer-
ase) (EC 2.7.1.20) [5]; efflux transport across the blood
brain barrier (BBB) and metabolic degradation into
nucleobases by the brain endothelial cells [6] and the
slow bulk flow of brain ISF, driven by the newly formed
ISF around the capillaries, which exits towards the cere-
brospinal fluid (CSF) [7]. Once adenosine molecules
reach the CSF by the bulk flow of ISF, they can then
either enter the systemic circulation or the lymph by
CSF bulk flow or they can be removed from ventricular
CSF into blood by efflux transport across the epithelium
of the four choroid plexuses (CPs), which form the
blood-cerebrospinal fluid barrier (BCSFB) in vivo. Efflux
transport of adenosine across the BCSFB depends pri-
marily on three factors: the surface area between the CP
epithelium and the CSF, which is expanded by the pre-
sence of microvilli on the apical side of the epithelium
and complex interdigitations between the lateral walls of
the epithelial cells [8]; the presence of nucleoside trans-
porters in the CP epithelium; and the concentration gra-
dient for this nucleoside across that epithelial layer.
In addition to their role in homeostasis of adenosine
and other naturally occurring nucleosides, hENTs and
hCNTs play a role in membrane transport of several
synthetic nucleosides, which act as nucleoside reverse
transcriptase inhibitors. Human nucleoside transport
protein hENT2, expressed in Xenopus oocytes, mediates
transport of 3’-azido-3’-deoxythymidine (AZT), 2’3’-
dideoxycytidine (ddC), and 2’3’-dideoxyinosine (ddI)
across the cell membrane [9]. Strazielle et al.h a v e
shown [10] that basolateral to apical influx transport of
AZT across the CP epithelium was significantly higher
(0.6 × 10
-3cm/min) than influx transport of the extracel-
lular space marker sucrose (0.19 × 10
-3cm/min); how-
ever, those authors also determined that the presence of
thymidine in the medium did not affect AZT influx
transport. ddI transport from blood into guinea pig
choroid plexus involves an organic anion transporting
polypeptide 2-like transporter, while its transport across
the BBB involves nucleoside transporters [11]. hCNT3
expressed in Xenopus laevis oocytes could mediate
transport of those synthetic nucleosides, but this activity
critically depended on the 3’-hydroxyl position in sub-
strates [12]. Thus, when compared to transport of thy-
midine via hCNT3, transport of AZT by this transporter
was moderate [12,13], while the transport of ddC and
ddI was low, when compared to transport of cytidine
and inosine by this transporter [12]. hENT3 can trans-
port AZT, ddC, and ddI [3].
In this study we used freshly isolated pieces of human
CP to explore the expression of hENTs and hCNTs at
the transcript level and to explore the in vitro uptake of
[
3H]inosine by the CP. Inosine was chosen for the
uptake studies because this nucleoside is a good sub-
strate for hENT1 and 2 [14], hENT3 [3] and hCNT3
[15], but the rate of its intracellular trapping by phos-
phorylation is much lower than for adenosine. This is
mainly because inosine kinase (ATP:inosine 5’-phospho-
transferase, EC 2.7.1.73) is absent from mammalian tis-
sues, including the whole brain homogenate [16] and
inosine has low affinity for adenosine kinase [17], which
is the most abundant nucleoside kinase in mammals.
The results in this study indicate that human CP
expressed three equilibrative nucleoside transporter
family members, hENTs 1-3, but only one type of con-
centrative nucleoside transporter, hCNT3; however, the
uptake of inosine by freshly isolated CP pieces was
found to be mediated primarily by just two transporter
types, hENT2 and hCNT3.
Methods
Tissue and ethical approval
Pieces of human CP used in this study represented spare
material from neurosurgery that, for various clinical
indications, had to be dissected from lateral ventricle
CPs. A total of 20 samples of apparently pathologically-
unaltered CP tissue, 21-48 mg wet weight each, were
collected in the Department of Neurosurgery, Clinical
Centre in Belgrade, Serbia over a period of four years
(2004 - 2008); the age of patients was 20-55 years. This
procedure conformed to the standards set by the
Declaration of Helsinki and was also in accordance with
the Human Tissue Act of 2004. The procedure had
been approved by the Ethics Committee of the Clinical
Centre Belgrade.
Radioisotopes and solutions
[2,8-
3H]Inosine (Specific Activity 20 Ci/mmol) was pur-
chased from ICN Pharmaceuticals (Costa Mesa, CA,
USA); [(U)-
14C]sucrose (Specific Activity: 400-700 mCi
(14.8-25.9 GBq mmol
-1)w a sp u r c h a s e df r o mP e r k i n
Elmer (Waltham, Massachusetts, USA). These isotopes
were used without further purification. The following
solutions were used for tissue processing and uptake
studies: Hank’s Balanced Salt Solution (HBSS) - based
buffer containing (mM) NaCl 138, KCl 5.33, NaHCO3
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HEPES 5; pH 7.4. Artificial CSF (aCSF) containing
(mM): NaCl 121, KCl 2.5, NaHCO3 18, urea 2, MgCl2
0.8, CaCl2 1.4, 2’-deoxy-D-glucose 10, 4-amido-5-iodo-
7-(b-D-ribofuranosyl)-pyrrolo [2,3-d] pyrimidine, also
known as 5-iodotubercidin (5-IT) 1 μM; pH 7.35.
Low Na
+aCSF, of the same composition as aCSF,
except that NaCl and NaHCO3 were replaced by choline
chloride and choline bicarbonate, respectively.
Tissue processing
During the neurosurgery hCP samples were placed
immediately in ice cold HBSS - based buffer and exam-
ined by a 10× magnification glass. Samples which were
obviously altered by various pathological processes were
excluded from the study. Tissue was either used for the
study immediately thereafter or frozen in liquid nitrogen
and kept at -80°C until use.
Quantification of mRNA encoding nucleoside transporters
Nomenclature used in this manuscript was according
to the “Minimum Information for Publication of Quan-
titative Real-Time PCR Experiments” guideline [18].
Total RNA was isolated from tissue using the standard
Trizol/chloroform/isopropanol procedure and RNA
pellets were dissolved in RNase-free, diethylpyrocarbo-
nate-treated water at 55°C for 10 min; all samples were
checked for RNA integrity and RNA concentrations
were determined from absorbance at 260 nm. In all
cases, 2 μg portions of total RNA were used for first-
strand cDNA synthesis. Intron-spanning primers were
used in the study that excluded interference from
genomic DNA in the results; however, all RNA sam-
ples were treated with DNA-ase, 4 units/sample (Invi-
trogen, Carlsbad, California, USA) prior to the reverse
transcription. Reverse transcription was performed
with MuMLV reverse transcriptase (RT) (Invitrogen)
using random hexamers (Invitrogen), according to the
manufacturer’s instructions. The samples in which the
RT was replaced by water (RT-ve) were considered as
negative controls.
Both RT+ve and RT-ve samples were used for qPCR.
In some cases, as explained below, the qPCR reactions
were also performed using a human (Raji) cDNA as a
control. This cDNA was obtained from immortalized
lymphoblastoid cells, derived from a Burkitt’s lymphoma
(ATCC #CCL86) and was supplied by the manufacturer
as a 25 ng.μl
-1 template. It was used as a positive con-
trol, to prove that the reverse transcription was per-
formed correctly and that the absence of hCNT1 and
hCNT2 transcripts in hCP was not due to ineffective
hydrolysis probes. In either case (cDNA synthesized
from the hCP mRNA or control cDNA), the template
was diluted to the final concentration of 250 ng.ml
-1;
then 1 μl cDNA template, which corresponds to 0.25 ng
cDNA, was used for the qPCR.
qPCR reactions were carried out in the Applied Bio-
systems 7500 real time model (Applied Biosystems, Fos-
ter City, California, USA) using the following gene
expression assays, which had intron-spanning primers
and hydrolysis probes labelled with 6-carboxyfluorescein
(FAM) as a reporter dye and 6-carboxy-tetramethyl-rho-
damine (TAMRA) as a quencher dye: hs01085706 for
hENT1, hs00155426 for hENT2, hs00983219 for
hENT3, hs00984403 for hCNT1, hs00188407 for
hCNT2, hs00223220 for hCNT3 and hs99999901 for
h18 S. The reaction mixture was prepared according to
the instructions from the manufacturer and consisted of
1 μl cDNA template (corresponded to 0.25 ng cDNA),
1.25 μl primer mix, RNase-free water and Taqman uni-
versal master mix (Applied Biosystems) up to 25 μl. The
PCR reactions were carried out in a 96-well plate that
was sealed with an adhesive transparent foil, employing
the thermal profile that was suggested by the manufac-
turer: 2 min at 50°C (1 cycle); 10 min at 95°C (1 cycle),
then 15 s at 95°C followed by 1 min annealing at 60°C
for 40 cycles. In some cases, a 5 μl sample of the PCR
product after 40 cycles was analyzed by electrophoresis
on a 1.5% agarose gel that contained ethidium bromide.
The gene accession numbers, probe and amplicon
sequences as well as the amplicon lengths are shown in
the Table 1. All samples were assayed and quantification
cycle (also known as threshold cycle) values (Cq) were
calculated for each gene of interest and for 18 S riboso-
mal RNA. For every sample those values were calculated
as averages of 2 replicates.
There seem to be two splice variants for hCNT3
[19,20], two splice variants of hENT2 (ENSEMBL entry
http://www.ensembl.org/Homo_sapiens/Gene/Summary?
db=core;g=ENSG00000174669;r=11:65886569-65895867;
t=ENST00000311161), nine splice variants of hENT1
http://www.ensembl.org/Homo_sapiens/Gene/Splice?
db=core;g=ENSG00000112759;r=6:44295220-44309866
and only one for hENT3 http://www.ensembl.org/
Homo_sapiens/Gene/Summary?g=ENSG00000198246.
However, there are no known splice variants or single-
nucleotide polymorphism positions documented in tran-
script and single-nucleotide polymorphism databases in
the regions of the genes corresponding to the portions
of the cDNA to be amplified in this study according to
the ENSEMBL entries or references mentioned above;
thus, use of intron-spanning primers could not affect
the quantification data in this study.
In some experiments, a series of dilutions of cDNA
was made (2-64 fold) and then qPCR reactions carried
out as explained above. The obtained Cq values for each
dilution for every nucleoside transporter and for 18 S
RNA were then plotted against the log dilution. The
Pearson product correlation coefficient (r) and slope of
the line shaped by those points were calculated and the
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E
slope 
 10
1/ (1)
In some experiments PCR products were collected
after 40 cycles and were subjected to electrophoresis
alongside a DNA ladder (Gibco, Carlsbad, CA, USA),
through a 2% (w/v) agarose gel (Boehinger Manheim,
Bracknell, Berkshire, UK) and stained with ethidium
bromide.
Uptake of [
3H]inosine
Fresh tissue was used for the uptake studies; after the
dissection into ~2 × 2 × 2 mm pieces, CP tissue was
pre-incubated for 30 min in 1 ml of warm (37°C) aCSF
or low Na
+aCSF, gassed with 5% CO2 in O2 and con-
taining 2-deoxy-D-glucose and 5-IT. CP pieces were
then transferred to 0.4 ml aCSF or low Na
+ aCSF con-
taining 911 ± 5 disintegrations per minute (DPM) μl
-1
(mean ± SEM from 25 samples) of [2,8-
3H]inosine and
655 ± 3 DPM μl
-1 (mean ± SEM from 17 samples) of
[(U)-
14C]sucrose as an extracellular space marker; unla-
belled inosine was added to give a final concentration
of 2 μM. Where indicated, the nucleoside transport
inhibitor NBMPR was added to aCSF at concentrations
of either 0.5 μMo r1 0μM.
After 1, 5 or 10 min of incubation at 37°C (as indi-
cated in the Results section), the tissue was rinsed in
ice-cold aCSF, weighed and solubilised in the tissue
solubilizer. The radioactivity in all samples was deter-
mined by liquid scintillation counting (LKB Wallac
1219, Turku, Finland) and counts per min were con-
verted into DPM using the internally stored quench
curve. The results were first calculated as [
3H] DPM/
mg protein, with the amount of protein in the tissue
having been determined according to the Bradford
assay [22]. To correct for [
3H]-radioactivity that
remained in the extracellular space of the CP, the [
14C]
DPM/mg protein value, which was multiplied by the
[
14C] DPM/[
3H] DPM ratio in the sample (a correction
factor), was subtracted from the total [
3H] DPM.
Finally, the net [
3H]radioactivity in the samples was
converted to moles inosine mg.protein
-1,t a k i n gi n t o
account specific activities of the tracer.
Statistical analysis
Uptake data are presented as means ± SEM. Analysis of
variance (ANOVA) was used to determine the signifi-
cance of differences between two or several groups. A
probability of p < 0.05 was taken as the limit of
significance.
Results and Discussion
Quantification of mRNA for nucleoside transporters
In order to show that the qPCR assays were quantita-
tive within the range of the cDNA input, as well as in
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Page 4 of 9order to estimate the efficiencies of the qPCR reactions,
a series of dilutions of CP cDNA was prepared and then
the quantification cycle, Cq, values determined for 18 S
RNA and for each gene of interest; a plot of log dilu-
tions against the obtained Cq values (Figure 1) demon-
strated a linear increase of Cq values with dilution with
the linear correlation coefficients 0.9949, 0.9905, 0.9933,
0.9927 and 0.9932 for 18 S RNA, hENT1, hENT2,
hENT3 and hCNT3, respectively. The amplification effi-
ciencies (E) under those conditions were 2.01, 1.93, 2.01,
2 . 0 2a n d2 . 0 0f o r1 8SR N A ,h E N T 1 ,h E N T 2 ,h E N T 3
and hCNT3, respectively.
Table 2 shows the average Cq values of nucleoside
transporters in hCP as well as the linear form of the Cq
values, E
-Cq. A total of 5 cDNA samples (obtained from
5 hCP samples) were measured. The Cq values in RT-ve
samples were above 40 (not shown in Table 2). The Cq
values in RT+ve samples for hCNT2 were above 40, so
they were not calculated either. The Cq values for
hCNT1 in 3 samples were above 40, while in 2 remain-
ing samples they were 38.6 and 39.4, indicating the
absence and very low abundance of mRNA, respectively.
The Cq values in RT+ve samples for hENTs 1-3 (29.0 ±
0.52, 28.08 ± 0.30, 19.17 ± 0.59) and for hCNT3 (27.67
± 0.43, Table 2) were much below the Cq values in RT-
ve samples. The Cq values in the control human (Raji)
cDNA for 18 S ribosomal RNA, hENT1, hENT2,
hENT3, hCNT1, hCNT2 and hCNT3 were (mean ± SD,
from 3 repeats) 14.6 ± 0.5, 27.1 ± 0.4, 25.2 ± 0.5, 25.6 ±
0.3, 38.8 ± 0.9, 39.0 ± 0.4 and > 40, respectively.
Electrophoresis of the PCR products revealed bands of
expected sizes for hENT1, hENT2, hENT3 and hCNT3
(Figure 2), while bands corresponding to hCNT1 and
hCNT2 were absent.
The obtained E
-Cq values (Table 2) indicated that by
far the most abundant mRNA was that for hENT3, with
the amount of mRNA being only about 40 fold less than
t h ea m o u n to f1 8SR N Ac o p i e s ;t h eh E N T 1 ,h E N T 2
Figure 1 Validation of the method for fluorescence-based quantitative real-time PCR (qPCR). Titration curves were obtained by using
cDNA to create a series of dilutions, from 1× (no dilution) to 64 × dilution. Then the qPCR was run and log dilutions plotted against the
obtained quantification cycle (Cq) values. Each Cq value was estimated as an average from 2 replicates and each point in the Figure represents
mean ± SE from 3 separate cDNA samples. The linearity of the plots shows the equal amplification of the assay over a range of input DNA
concentrations. These data were also used to estimate the efficiency (E) of the reaction for each gene of interest.
Table 2 The fluorescence-based quantitative real-time
PCR data for the reference gene and genes of interest in
human choroid plexus.
Cq ± SD
(n = 5)
E
-Cq ±S D( ×1 0
9)
18 S 13.97 ± 0.31 58123 ± 12920
hENT1 29.00 ± 0.52 5.23 ± 1.79
hENT2 28.08 ± 0.30 3.07 ± 0.62
hENT3 19.17 ± 0.59 1403 ± 494
hCNT1 > 40 -
hCNT2 > 40 -
hCNT3 27.67 ± 0.43 4.69 ± 1.35
Values are presented as mean ± SD from 5 separate CP samples. For every
sample the quantification or threshold cycle (Cq) value was calculated as an
average from 2 replicates. The linear form of the Cq values was corrected for
the reaction efficiency (E), and is presented as E
-Cq. The Cq value was much
lower for hENT3 than for other ENTs and CNTs, indicating that this nucleoside
transporter was the most abundant at the transcript level.
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2 fold less abundant
than the amount of hENT3 mRNA. It has been reported
that the hENT3 protein was found to co-localize with
lysosomal markers and showed broad selectivity and low
affinity towards the naturally occurring nucleosides [3];
the later report indicated that hENT3 was in several
human cell lines also a mitochondrial transporter [4],
which can also transport several nucleoside reverse tran-
scriptase inhibitors, including AZT, ddI and ddC [4].
Immunoreactivity at cellular membrane was also
detected, but only in human placental cell lines [4]. This
transporter is relatively insensitive to NBMPR and is
strongly dependent upon pH, with its maximum activity
at pH 5.5 [3,4]. Bearing in mind that the mitochondrial
matrix pH in mammalian cells is slightly alkaline and
that the local pH in the intracristal compartments is
acidic [23], a condition required for optimal function of
the ATP synthase [24], such a gradient provides good
conditions for hENT3 activity. A physiological role for
hENT3 may be in salvaging nucleosides and deoxynu-
cleosides into the mitochondria, which may be followed
by subsequent phosphorylation by intramitochondrial
kinases. This process may play a role in mitochondrial
DNA synthesis and repair in CP epithelium. This role
was also suggested in a report describing two missense
m u t a t i o n sa n do n es i n g l en u c l e o t i d ed e l e t i o ni nt h e
hENT3 gene as a cause of an autosomal recessive disor-
der called the H syndrome [25].
Uptake of
3H-inosine
To avoid saturation of the transport systems, nucleoside
uptake studies were performed using a concentration of
inosine of 2 μM, which was substantially less than the
reported Km values of approximately 170 μMa n d5 0
μM for hENT1 and hENT2 respectively [2]. The uptake
values for inosine by CP tissue in the aCSF (presence of
Na
+) after 5 and 10 min of incubation were significantly
higher than the corresponding uptake values seen in Na
+-free aCSF (p < 0.01, Figure 3). Uptake of inosine after
5 min (n = 3) and 10 min (n = 3) of incubation in the
presence of 0.5 μMN B M P Ri nN a
+-free aCSF did not
differ significantly from the corresponding uptake after
incubation in Na
+-free aCSF which did not contain
NBMPR (Figure 3, p > 0.05). However, the presence of
10 μMN B M P Ri nN a
+-free aCSF caused significant
inhibition of inosine uptake after 5 min (n = 4, p <
0.01) and after 10 min (n = 3, p < 0.001), when com-
pared to the uptake in Na
+-free aCSF which did not
contain NBMPR.
The hENT1 and 2 proteins as well as hCNTs are pri-
marily located in the plasma membrane. However, these
transporters differ in that hENT1 is inhibited by nano-
molar concentrations of NBMPR (IC50 0.4 ± 0.1 nM),
while hENT2 is ~7000-fold more resistant to inhibition
(IC50 2.8 ± 0.3 μM) [2]. The observation in the present
study that 0.5 μM NBMPR failed to cause significant
inhibition of [
3H]inosine accumulation into CP pieces
(Figure 3) indicated that the hENT1 protein, which was
present at the transcript level, did not contribute to
nucleoside uptake by the CP pieces in vitro.
There are several possible explanations for this find-
ing: one of those could be that hENT1 is confined to
the basolateral membrane of the CP epithelium; our
previous study on rat CP epithelium in primary culture
has also shown that rENT1 was confined to the intersti-
tial fluid - facing membrane [26]. The rationale behind
this explanation is that the uptake study was performed
on isolated samples of human CP, thus no perfusion
pressure was present in the microcirculation, a situation
which could cause CP capillaries to collapse. Bearing in
mind the histological structure of the CP, the diffusion
of solutes from the aCSF into the CP interstitial fluid
under these circumstances would be rather limited. On
the other hand, the existence of tight junctions between
epithelial cells of the CP occludes paracellular space and
further impedes diffusion of solutes from the aCSF into
Figure 2 A typical agarose gel obtained after electrophoresis of the PCR products, stained with ethidium-bromide. Bands of expected
sizes were obtained for hENT1, hENT2, hENT3 and hCNT3, while bands corresponding to hCNT1 and hCNT2 were absent.
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membrane. Therefore, exposure of the basolateral side
of the CP epithelium, which faces CP interstitial fluid
and CP capillaries, to radiotracers in the aCSF could be
considered fairly limited in this study.
Uptake of [
3H]inosine was reduced significantly by the
presence of 10 μM NBMPR (Figure 3); this pattern of
inhibition is consistent with involvement of hENT2 in
the uptake process. This is in accordance with presence
of mRNA encoding hENT2. A role for other transpor-
ters that are weakly inhibited by NBMPR could be
excluded. Inosine is a permeant for hENT3 [3], which
was the most abundant nucleoside transporter at the
transcript level in the human CP (Table 2). However, it
is unlikely that this transporter contributed to the accu-
mulation of [
3H]inosine in the CP pieces because of its
cellular localization and pH dependence.
Functional uptake studies also revealed that depletion
of Na
+ from the aCSF caused significant reduction
(~25-30%) of inosine uptake by human CP (Figure 3),
which was consistent with the involvement of hCNTs.
The RT-qPCR data revealed that mRNA for hCNT3 was
present in CP samples while mRNAs for hCNT1 and for
hCNT2 were not detectable. This finding indicates that
the Na
+-dependent uptake was probably mediated by
hCNT3, a transporter that is broadly selective and trans-
ports both purine and pyrimidine nucleosides into cells,
employing a 2:1 Na
+ : nucleoside coupling ratio [15].
Inosine is a natural substrate for inosine kinase (IK); it
was initially believed that this enzyme was also present
in mammalian tissues [27,28], but it was revealed later
that inosine phosphorylation was in fact due to the
phosphotransferase activity of cytosolic 5’-nucleotidase
[29]; thus, IK (and guanosine kinase) were absent in sev-
eral mammalian tissues, including whole brain homoge-
nate [16]. On the other hand, adenosine kinase (AK) is
the most abundant nucleoside kinase in mammalian tis-
sues, with high affinity for its natural substrate, adeno-
s i n e( K m1 . 9 8m i c r o M-[ 5 ] ) .I tw a sb e l i e v e dt h a tA K
does not have any inosine kinase activity [30]. However,
it was found later that inosine analogues could be sub-
strates for the AK, but that depended on the ionization
of N1 atom, which in turn depended on pH [17]. The
substitution of an N-atom for the C-8 atom of this
nucleoside lowers the pKa, so that the N-1 proton is
more ionized at pH 7.00; this ionized form resembled
adenosine with respect to the bond structure at the 1
and 6 positions of the purine ring, whereas the un-
ionized form (as it is in inosine itself) does not [17].
Thus, since inosine pKa is 8.74, the rate of its phosphor-
ylation by AK at pH 7.00 is very low because N-1 pro-
ton is 2% ionized; however, at higher pH that rate
increases. The pH of the artificial CSF in our study was
7.3-7.4, at that pH the N1 of inosine is more ionized, so
we believed that this nucleoside could be, to some
extent, a substrate for the AK. That was the rationale
behind inhibition of AK in our study by 5-IT, which
was present at a concentration which was sufficient to
completely inhibit AK according to the published half
maximal inhibitory concentration (IC50) [31].
Figure 3 The uptake of [
3H] inosine into human CP incubated in aCSF containing 139 mEq Na
+ (squares), Na
+-free aCSF medium
(triangles), and Na
+-free aCSF medium containing either 0.5 μM S-(4-Nitrobenzyl)-6-thioinosine (NBMPR) (circle) or 10 μM NBMPR
(deltoid). The data are presented as means ± SEM from 3-4 separate experiments. The uptake values for inosine by CP tissue in aCSF (presence
of Na
+) after 5 and 10 min of incubation were significantly higher than the corresponding uptake values seen in Na
+-free aCSF (p < 0.01).
Uptake of inosine after 5 min (n = 3) and 10 min (n = 3) of incubation in the presence of 0.5 μM NBMPR in Na
+-free aCSF did not differ
significantly from the corresponding uptake after incubation in Na
+-free aCSF which did not contain NBMPR (p > 0.05). The presence of 10 μM
NBMPR in Na
+-free aCSF caused significant inhibition of inosine uptake after 5 min (n = 4, p < 0.01) and after 10 min (n = 3, p < 0.001), when
compared to the uptake in Na
+-free aCSF which did not contain NBMPR.
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that show various affinities for purine ribo- and deoxyri-
bonucleosides [32]; all those enzymes have ATP as a
donor of activated phosphate. Thus, prior to the uptake
studies, a 30 min pre-incubation was performed in a
glucose-free aCSF, which contained 10 mM 2’-deoxy-D-
glucose, an analogue which cannot be metabolized
beyond the 6-phosphate form and therefore competi-
tively inhibits glycolysis and the resulting production of
pyruvate. It has been shown that incubation of astro-
cytes and neurons with 10 mM 2’-deoxy-D-glucose in
the absence of D-glucose (the strategy that was used in
this study) caused depletion of > 90% of cellular ATP
[33], while ATP content in lymphocytes after 1 h incu-
bation in medium containing both 2’-deoxy-D-glucose
and D-glucose was reduced only 20-30% [34]. Several
lines of evidence suggest that glucose is the main fuel
for the CP epithelium: human CP epithelium abundantly
expresses GLUT1 mainly in the basolateral membrane
[35]; rat CP and ependyma had the highest expression
of GLUT1 in the brain [36].
It should be noted that the plasma membrane monoa-
mine transporter (PMAT) can, at pH 5.5, also transport
naturally occurring nucleosides, thus it is alternatively
known as hENT4 [37]. However, expression of this
transporter was not investigated because this monoa-
mine transporter has a poor ability to transport purine
nucleosides at 7.3-7.4. The pH of human CSF is 7.31-
7.35 [38] and the pH does not go below 6.8 even in
metabolic acidosis [38], acute respiratory acidosis [39],
head injury [40] and brain hypoperfusion [41].
Conclusions
This study described the presence of individual nucleo-
side transporters at the transcript level and their func-
tional activities in fresh human CP. The most abundant
nucleoside transporter at the transcript level in hCP was
hENT3; this tissue also expressed hENT1, hENT2 and
hCNT3 at the level of transcripts. Both concentrative
and equilibrative nucleoside transport processes were
clearly detectable, the latter was probably mediated by
hENT2, while ENT1-mediated transport could not be
detected.
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